Novartis AG (NVS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Novartis AG

    NYSE: NVS · Real-Time Price · USD
    123.43
    -0.22 (-0.18%)
    At close: Sep 26, 2025, 3:59 PM

    Novartis Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 51.72B 46.66B 51.83B 52.88B
    Cost of Revenue
    		 12.83B 12.47B 15.49B 15.87B
    Gross Profit
    		 38.9B 34.19B 36.34B 37.01B
    Operating Income
    		 14.54B 9.77B 9.2B 26.95B
    Interest Income
    		 568M 627M 377M 71M
    Pretax Income
    		 13.64B 9.12B 8.37B 26.14B
    Net Income
    		 11.94B 14.85B 6.96B 24.02B
    Selling & General & Admin
    		 12.57B 12.49B 14.25B 14.89B
    Research & Development
    		 10.02B 11.37B 10B 9.54B
    Other Expenses
    		 1.76B 559M 2.9B 895M
    Operating Expenses
    		 24.35B 24.42B 27.14B 25.32B
    Interest Expense
    		 1.04B 873M 833M 905M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 37.18B 36.89B 42.63B 41.19B
    Income Tax Expense
    		 1.7B 551M 1.42B 2.12B
    Shares Outstanding (Basic)
    		 2.02B 2.08B 2.18B 2.24B
    Shares Outstanding (Diluted)
    		 2.04B 2.09B 2.2B 2.26B
    EPS (Basic)
    		 5.92 7.15 3.19 10.71
    EPS (Diluted)
    		 5.87 7.10 3.17 10.63
    EBITDA
    		 20.71B 18.29B 14.73B 17.13B
    EBIT
    		 14.65B 9.98B 7.98B 11.7B
    Depreciation & Amortization
    		 6.07B 8.28B 6.71B 5.43B

    Add to Watchlist